GEA has supplied one of the largest drug manufacturers in Korea with manufacturing equipment for a state-of-the-art pharma production plant. More than 7,000 VESTA® sterile valves were installed to direct the product flow in two identical insulin production lines. This was the first time VESTA® valve technology had been selected to completely equip a new greenfield project. The multimillion Euro order represents the biggest project so far in the history of the VESTA® line.
Caplin Group partners with GEA, a leading supplier of pharmaceutical containment equipment, to establish a state-of-the-art oncology plant in Chennai. Learn how Caplin's expansion plans and GEA's end-to-end solutions will enhance their production capabilities and deliver high-quality medicines.
Discover GEA's groundbreaking partnership with Oncogen Pharma in Malaysia, as they secure a multi-million Euro contract for the production of oral solid dosage (OSD) forms to treat cancer. Learn how GEA's end-to-end solutions and innovative technologies overcame challenges during the COVID-19 pandemic, ensuring successful project completion and customer satisfaction.
With the recent inclusion of a suite of fully automated, highly efficient production equipment to manufacture tablets and capsules, Pfizer’s plant in Freiburg, Germany, has been transformed into what the company calls a “Smart Factory.”
بعد إجراء بحث مكثف حول السوق، أكدت Penn Pharma وجود حاجة متزايدة في سوق الجرع الصلبة الخاصة بالأورام فيما يخص مجالي التطوير وإنتاج العقاقير عالية السميّة الذين يتم إسنادهما لجهات خارجية. حيث كان موقع الإنتاج الخاص بها يقوم بتصنيع منتجات الجرع الصلبة لأكثر من 20 عامًا، ولكنه يحتاج لقدرة استيعابية إضافية.